Long-term Tecfidera use was found to significantly reduce relapse rates and slow disability progression for MS patients in a ...

Tuberculosis (TB) is the world's biggest infectious disease killer, with multidrug-resistant TB (MDR-TB) posing a particular ...

Traveling can be a challenging experience for anyone, but for those living with Multiple Sclerosis (MS), it often comes with ...

Age is a major modifier of inflammatory CSF signatures in MS. This finding identifies novel biomarker candidates and potential therapeutic targets.